275 related articles for article (PubMed ID: 23986411)
21. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
Nastro E; Musolino C; Allegra A; Oteri G; Cicciù M; Alonci A; Quartarone E; Alati C; De Ponte FS
Acta Haematol; 2007; 117(3):181-7. PubMed ID: 17164581
[TBL] [Abstract][Full Text] [Related]
22. [Bilateral maxillary bisphosphonate-related osteonecrosis of the jaw: a case report].
Meng PQ; Guo YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1098-1102. PubMed ID: 29263490
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate.
Badel T; Pavicin IS; Carek AJ; Rosin-Grget K; Grbesa D
Coll Antropol; 2013 Jun; 37(2):645-51. PubMed ID: 23941019
[TBL] [Abstract][Full Text] [Related]
24. Identification of Risk Factors for Bisphosphonate-Associated Atypical Femoral Fractures and Osteonecrosis of the Jaw in a Pharmacovigilance Database.
Bejhed RS; Kharazmi M; Hallberg P
Ann Pharmacother; 2016 Aug; 50(8):616-24. PubMed ID: 27179251
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
26. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
[TBL] [Abstract][Full Text] [Related]
27. Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.
Capalbo S; Delia M; Diomede D; Dargenio M; Chiefa A; Favia G; Liso V
Int J Hematol; 2006 Jun; 83(5):439-42. PubMed ID: 16787865
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
29. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Van Poznak C; Estilo C
Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
31. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
32. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
33. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
Eid A; Atlas J
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
[TBL] [Abstract][Full Text] [Related]
34. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
Statz TA; Guthmiller JM; Humbert LA; Johnson GK
J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
[TBL] [Abstract][Full Text] [Related]
36. Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report.
Wu XH; Chen SW
Medicine (Baltimore); 2023 Jul; 102(29):e34260. PubMed ID: 37478232
[TBL] [Abstract][Full Text] [Related]
37. [Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report].
Wu PF; Li Y; Lei ZG; Chen LL
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Aug; 38(4):460-463. PubMed ID: 32865369
[TBL] [Abstract][Full Text] [Related]
38. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
Goodwin JS; Zhou J; Kuo YF; Baillargeon J
Mayo Clin Proc; 2017 Jan; 92(1):106-113. PubMed ID: 27876314
[TBL] [Abstract][Full Text] [Related]
39. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
40. Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report.
Preidl RH; Ebker T; Raithel M; Wehrhan F; Neukam FW; Stockmann P
BMC Gastroenterol; 2014 Jan; 14():6. PubMed ID: 24400722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
